Nissan North America, Inc.
Summary
NHTSA campaign 25V437: Nissan North America, Inc. recalled for a safety defect. Engine failure increases the risk of a crash. A bearing failure may cause a breach in the engine block, allowing hot oil
Details
Source
nhtsa
External ID
25V437
Action Date
2025-06-27
Status
Ongoing
Category
vehicle
Product Description
Nissan North America, Inc. (Nissan) is recalling certain 2021-2024 Rogue, 2019-2020 Altima, 2019-2022 Infiniti QX50, and 2022 Infiniti QX55 vehicles equipped with 3-cylinder 1.5L or 4-cylinder 2.0L variable compression turbo (VC-Turbo) engines. The engine bearings may have manufacturing defects that can lead to engine failure.
Company
Context & Analysis
Nissan North America, Inc. has 85 FDA actions in our database.
Frequently Asked Questions
How often does Nissan North America, Inc. have FDA actions?
Nissan North America, Inc. has 85 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle